GAFFAR SYED: Open Payments
NPI 1013976687 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 28 payments from 12 companies in 2025. Trend: 2023 $532 · 2024 $604 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $109 |
| Exact Sciences Corporation | 4 | $107 |
| ANI Pharmaceuticals, Inc. | 3 | $82 |
| PFIZER INC. | 3 | $69 |
| Lilly USA, LLC | 3 | $60 |
| ABBVIE INC. | 2 | $44 |
| Indivior Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: Cologuard Collection Kit, PURIFIED CORTROPHIN GEL, Ozempic, VYNDAQEL, VRAYLAR, Wegovy, ELIQUIS, SUBLOCADE.
Industry payments across MD — which companies pay providers there.
